| Schedule of Restricted Stock Unit Activity |
Restricted stock unit activity was as follows during the periods indicated: | | | | | | | | | | | | | | | | | | | Three Months Ended March 31, 2024 | | Three Months Ended March 31, 2023 | | Restricted Stock Units | | Weighted Average Grant Date Fair Value | | Restricted Stock Units | | Unvested at beginning of period | 12,636,460 | | | $ | 29.23 | | | 10,377,568 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Granted | 5,543,344 | | | 15.51 | | | 4,452,672 | | | | | | | | | Vested | (1,359,913) | | | 38.24 | | | (633,337) | | | Forfeited | (1,345,421) | | | 30.19 | | | (929,469) | | | Unvested at end of period | 15,474,470 | | | 23.44 | | | 13,267,434 | |
Restricted stock activity was as follows during the periods indicated: | | | | | | | | | | | | | | | | | | | Three Months Ended March 31, 2024 | | Three Months Ended March 31, 2023 | | Restricted Stock | | Weighted Average Grant Date Fair Value | | Restricted Stock | | Unvested at beginning of period | 347,976 | | | $ | 34.55 | | | 858,560 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Vested | (225,560) | | | 46.61 | | | (242,680) | | | Forfeited | — | | | — | | | (6,733) | | | Unvested at end of period | 122,416 | | | 12.32 | | | 609,147 | |
|
| Schedule of Unvested Options Activity |
Options activity was as follows during the period indicated: | | | | | | | | | | | | | | | | | | | Three Months Ended March 31, 2024 | | Three Months Ended March 31, 2023 | | Options | | Weighted Average Exercise Price | | Options | | Outstanding at beginning of period | 279,553 | | | $ | 21.00 | | | 323,002 | | | | | | | | | Exercised | — | | | — | | | (11,236) | | | Expired | (6,474) | | | 21.00 | | | (10,095) | | | Forfeited | — | | | — | | | (3,106) | | | Outstanding at end of period | 273,079 | | | 21.00 | | | 298,565 | |
Options have a maximum contractual term of ten years. The aggregate intrinsic value and weighted average remaining contractual terms of Options outstanding and Options exercisable were as follows as of March 31, 2024: | | | | | | | March 31, 2024 | Aggregate intrinsic value (in millions)(1) | | Options outstanding | $ | — | | Options exercisable | — | | | Weighted average remaining contractual term (in years) | | Options outstanding | 6.0 years | Options exercisable | 6.0 years | ________________ (1)The aggregate intrinsic value of options outstanding and exercisable is zero, as all options are out of the money
|
| Schedule of Unamortized Equity-Based Compensation Costs |
As of March 31, 2024, unamortized equity-based compensation costs related to each equity-based incentive award described above is the following: | | | | | | | | | | | | (in millions) | Amount | | Weighted Average Remaining Service Period (in years) | | Restricted stock units | $ | 314.7 | | | 2.7 | | | | | | Restricted stock | 0.3 | | | 0.4 | | | | | | | | | | | | | | HSKB Phantom Units | 12.4 | | | 2.6 | | Employee Stock Purchase Plan | 0.5 | | | 0.2 | | Total unamortized equity-based compensation cost | $ | 327.9 | | | 2.7 |
|